A detailed history of Groupama Asset Managment transactions in Astrazeneca PLC stock. As of the latest transaction made, Groupama Asset Managment holds 543,398 shares of AZN stock, worth $35.5 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares
543,398
Previous 442,173 22.89%
Holding current value
$35.5 Million
Previous $68.7 Billion 1.35%
% of portfolio
1.76%
Previous 0.93%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$76.67 - $87.62 $7.76 Million - $8.87 Million
101,225 Added 22.89%
543,398 $67.8 Billion
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $3.82 Million - $4.62 Million
57,180 Added 14.85%
442,173 $68.7 Billion
Q1 2024

May 14, 2024

BUY
$61.03 - $69.57 $23.5 Million - $26.8 Million
384,993 New
384,993 $51.9 Billion

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.